Home
Font Size:
1
2
3
Send to a Friend
Company
Mission
History
About Us
Awards
Contact
Driving Directions
Technology
Product Pipeline
MORAb-004
Farletuzumab
MORAb-009
Preclinical Pipeline
Clinical Trials
Farletuzumab
MORAb-004
MORAb-009
Partnerships
Research Alliances
News & Events
2010 News
2009 News Archive
2008 News Archive
2007 News Archive
2006 News Archive
2005 News Archive
2004 News Archive
2003 News Archive
2002 News Archive
2001 News Archive
Events
Careers
Current Job Openings
Our Work Environment
Benefits
Farletuzumab
MORAb-004
MORAb-009
MORAb-009
"An Efficacy Study of MORAb-009 in Patients with Pancreatic Cancer"
This Phase II trial has completed recruitment in previously untreated patients with advanced pancreatic cancer in select centers around the world
Click here
for additional information about this trial.
"An Efficacy Study of MORAb-009 in Patients with Pleural Mesothelioma"
This Phase II trial is currently recruiting previously untreated patients with malignant pleural mesothelioma in select centers around the world
Click here
for additional information about this trial.